These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20486869)

  • 1. Significant hyperkalemia and hyponatremia secondary to telmisartan/hydrochlorothiazide treatment.
    Cakir M
    Blood Press; 2010 Dec; 19(6):380-2. PubMed ID: 20486869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan/hydrochlorothiazide: a new fixed dose combination.
    Maillard M; Burnier M
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):375-86. PubMed ID: 15889965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR; Rolfe M
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Hyponatremia Associated with the Use of Angiotensin II Receptor Blocker/thiazide Combinations.
    Kim DR; Cho JH; Jang WS; Kim JS; Jeong KH; Lee TW; Ihm CG
    Electrolyte Blood Press; 2013 Dec; 11(2):56-9. PubMed ID: 24627706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
    Horký K
    Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients.
    Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P
    J Hum Hypertens; 2006 Mar; 20(3):177-85. PubMed ID: 16306998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.
    Kolasinska-Malkowska K; Filipiak KJ; Gwizdala A; Tykarski A
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):759-71. PubMed ID: 18510491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide.
    Ferreira O; Mota A; Morais P; Cunha AP; Azevedo F
    Cutan Ocul Toxicol; 2010 Dec; 29(4):293-5. PubMed ID: 20522001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperpigmentation Induced by Combination Therapy With Telmisartan-Hydrochlorothiazide.
    Giménez-García R
    J Clin Hypertens (Greenwich); 2016 Apr; 18(4):361-2. PubMed ID: 26360127
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
    Maillard MP; Burnier M
    Vasc Health Risk Manag; 2007; 3(3):265-78. PubMed ID: 17703634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of the renal prostanoids to a short-term depletion of sodium or potassium in healthy women.
    Agnoli GC; Borgatti R; Cacciari M; Garutti C; Ikonomu E; Lenzi P; Marinelli M; Stipo L
    Boll Soc Ital Biol Sper; 1996; 72(3-4):109-16. PubMed ID: 8771911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iatrogenic disease due to amiloride-hydrochlorothiazide combination. 12 cases].
    Houdent C; Gruber D; Levavasseur F; Wolf LM; Joram F; Le Bihan G; Bourreille J
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):628-31. PubMed ID: 1008389
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactions between acute effect of angiotensin converting enzyme inhibition and salt balance on the renal function and urinary prostanoids. Studies in healthy women.
    Agnoli GC; Borgatti R; Cacciari M; Garutti C; Ikonomu E; Lenzi P; Marinelli M; Stipo L
    Boll Soc Ital Biol Sper; 1996; 72(3-4):117-24. PubMed ID: 8771912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.
    Pichler RH; de Boer IH
    Curr Diab Rep; 2010 Aug; 10(4):297-305. PubMed ID: 20532701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan potassium/hydrochlorothiazide (Preminent®) and hyponatremia: case series of 40 patients.
    Kinoshita H; Kobayashi K; Yaguramaki T; Yasuda M; Fujiki K; Tomiyama J; Koga N; Yakushiji F
    Hum Exp Toxicol; 2011 Sep; 30(9):1409-14. PubMed ID: 20974655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of combined drugs (ARB and diuretics)].
    Arakawa K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():662-5. PubMed ID: 15171452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.